Covid-19 roundup: Europe to seek clarification on Pfizer/BioNTech delays; J&J predicts 100M doses for US by April
With reports over slowed distribution of the Pfizer/BioNTech vaccine and threats of lawsuits dangling, the European Commission is planning to ask the company for a clarification over delivery timelines.
A spokesman for the EU’s executive branch made the comments early Friday, according to a Reuters report. Pfizer and the Commission had earlier said that there would be no more slowdowns next week as it continues to alter a manufacturing site in Belgium to ramp up production.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.